Austria vs Mexico: Number of clinical trials

Austria
86 trials
in 2024
Mexico
68 trials
in 2024
Austria rank
28th
Mexico rank
31st

Number of clinical trials over time

  • Austria
  • Mexico
0255075100200020122024

How they compare

Austria currently reports 86 trials against 68 trials in Mexico, a difference of 18 trials.

That makes Austria's figure about 1.3 times Mexico's.

The two have swapped places 3 times across 24 shared years of data; in 2000 it was Mexico ahead.

Austria ranks 28th and Mexico ranks 31st of 153 countries.

Austria has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Austria Mexico Difference Ahead
2000s 23.44 trials 12.44 trials 11 trials Austria
2010s 85.6 trials 53.8 trials 31.8 trials Austria
2020s 102.8 trials 83.4 trials 19.4 trials Austria

Averages of every year both report within each decade.

Frequently asked questions

Which has higher number of clinical trials, Austria or Mexico?
Austria, at 86 trials against 68 trials in Mexico as of 2024.
What is the difference in number of clinical trials between Austria and Mexico?
18 trials, with Austria ahead.
How many years of comparable data are there for Austria and Mexico?
24 years are reported by both, from 2000 to 2024.
How do Austria and Mexico rank globally for number of clinical trials?
Austria ranks 28th and Mexico ranks 31st of 153 countries.
Where does this data come from?
ClinicalTrials.gov (2025) – with major processing by Our World in Data, published as Number of clinical trials. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator
Number of clinical trials
Unit
trials
Source
ClinicalTrials.gov (2025) – with major processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
153 places, 2,621 data points, 2000–2024
Last refreshed

Annual number of completed clinical trials registered in the ClinicalTrials.gov database for each country. Registration in the ClinicalTrials database is mandatory for trials in the United States, but voluntary for other countries.